Postoperative cognitive dysfunction: an acute approach for the development of novel treatments for neuroinflammation
Here we discuss the use of postoperative cognitive decline (POCD), which is hypothesised to have a neuroinflammatory basis, as an acute indication to demonstrate the efficacy of novel neuroinflammatory drugs.
Latent inhibition and its potential as a biomarker for schizophrenia
Here we provide a brief review of the history behind latent inhibition and the limitations of existing human paradigms, before discussing a more recent latent inhibition task modification and its potential as a biomarker for schizophrenia.
